Robert G. Moses

ORCID: 0000-0003-4177-9105
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gestational Diabetes Research and Management
  • Pregnancy and preeclampsia studies
  • Bariatric Surgery and Outcomes
  • Diabetes Management and Research
  • Birth, Development, and Health
  • Diabetes Treatment and Management
  • Diabetes Management and Education
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Metabolism, Diabetes, and Cancer
  • Diet and metabolism studies
  • Pharmacology and Obesity Treatment
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes and associated disorders
  • Obesity and Health Practices
  • Prenatal Substance Exposure Effects
  • Maternal and fetal healthcare
  • Mobile Health and mHealth Applications
  • Dietetics, Nutrition, and Education
  • Diet, Metabolism, and Disease
  • Obesity, Physical Activity, Diet
  • Health Literacy and Information Accessibility
  • Ovarian function and disorders
  • Medical Coding and Health Information
  • Maternal Mental Health During Pregnancy and Postpartum
  • Nutritional Studies and Diet

Illawarra Shoalhaven Local Health District
2013-2024

Australian Diabetes Society
2008-2021

Wollongong Hospital
2011-2020

University of Wollongong
1997-2020

Illawarra Health and Medical Research Institute
1999-2013

RMIT University
2013

South Eastern Sydney Local Health District
2013

Sydney South West Area Health Service
2009-2010

Oregon Health & Science University
2007

University of Miami
2007

OBJECTIVE: To compare the effect of repaglinide in combination with metformin monotherapy each drug on glycemic control patients type 2 diabetes. RESEARCH DESIGN AND METHODS: A total 83 diabetes who had inadequate (HbA1c > 7.1%) when receiving antidiabetic agent were enrolled this multicenter, double-blind trial. Subjects randomized to continue their prestudy dose (n = 27), addition or receive alone 29). For repaglinide, optimal was determined during a 4- 8-week titration and...

10.2337/diacare.22.1.119 article EN Diabetes Care 1999-01-01

OBJECTIVE A low–glycemic index diet is effective as a treatment for individuals with diabetes and has been shown to improve pregnancy outcomes when used from the first trimester. commonly advised women gestational mellitus (GDM). However, efficacy of this advice associated have not systematically examined. The purpose study was determine whether prescribing GDM could reduce number requiring insulin without compromise outcomes. RESEARCH DESIGN AND METHODS All seen over 12-month period were...

10.2337/dc09-0007 article EN cc-by-nc-nd Diabetes Care 2009-03-11

Objective: The International Association of Diabetes and Pregnancy Study Groups (IADPSG) has proposed new criteria for the diagnosis gestational diabetes mellitus (GDM). aim this study was to compare prevalence GDM when IADPSG were used with current Australasian in Society (ADIPS) used. Design, setting participants: This a prospective over 6-month period, examining results all glucose tolerance tests (GTTs) conducted Wollongong, city using public private sectors. Main outcome measures:...

10.5694/j.1326-5377.2011.tb03001.x article EN The Medical Journal of Australia 2011-04-01
Erin A. Bohula Benjamin M. Scirica Silvio E. Inzucchi Darren K. McGuire Anthony Keech and 95 more Steven R. Smith Estella Kanevsky Sabina A. Murphy Lawrence A. Leiter Jamie P. Dwyer Ramón Corbalán Christian W. Hamm Lee M. Kaplan José Carlos Nicolau Ton Oude Ophuis Kausik K. Ray Mikhail Ruda Jindřich Špinar Tushar Patel Wenfeng Miao Carlos Perdomo Bruce H. Francis Shobha Dhadda Marc P. Bonaca Christian T. Ruff Marc S. Sabatine Stephen D. Wiviott Marc S. Sabatine Stephen D. Wiviott Benjamin M. Scirica Silvio E. Inzucchi Anthony Keech Darren K. McGuire Steven R. Smith Andrew Satlin Conville Brown Andrzej Budaj Ramón Corbalán Jamie P. Dwyer Armando García-Castillo Milan Gupta Christian W. Hamm Lee M. Kaplan Anthony Keech Lawrence A. Leiter José Carlos Nicolau Ton Oude Ophuis Kauski Ray Mikhail Ruda Benjamin M. Scirica Jindřich Špinar Neil J. Weissman Harvey D. White Stephen D. Wiviott John Amerena Margaret Arstall David Colquhoun Rohan Jayasinghe A Lee Richard Lehman Robert G. Moses Joeseph Proietto P Purnell J. Waites Peter Blombery DeWitte T. Cross M. Worthley Michael C dʼEmden Joseph B. Selvanayagam RE Oqueli Alexandra Whelan P. Garrahy Fred de Looze Daniel M. Ninio John D. Horowitz Maged William Michael Suranyi Gary Wittert M. Le May AS Pandey Saul Vizel Rachel C. Labonte Y Beaudry Claude Fortin Avery Davis Bell Simon Kouz Eric St-Amour Iqbal Bata François Maurice R Chehayeb Christian Constance Grace Lai‐Hung Wong Andreas Heß Joanne Liutkus P. Poirier Isaac Teitelbaum Joseph Berlingieri Jinah Cha M Hartleib M Heffernan

10.1016/s0140-6736(18)32328-6 article EN The Lancet 2018-10-04

OBJECTIVE—Insulin glulisine is a novel analog of human insulin designed for use as rapid-acting insulin. This study compared the safety and efficacy with regular (RHI) in combination NPH RESEARCH DESIGN AND METHODS—In total, 876 relatively well-controlled patients type 2 diabetes (mean HbA1c 7.55%) were randomized treated glulisine/NPH (n = 435) or RHI/NPH 441) up to 26 weeks this randomized, multicenter, multinational, open-label, parallel-group study. Subjects allowed continue same dose...

10.2337/diacare.27.10.2363 article EN Diabetes Care 2004-10-01

The oral glucose tolerance test (OGTT) has, to date, been considered the cornerstone of diagnosis gestational diabetes mellitus (GDM). This is despite ongoing national and international disagreement regarding which women require testing, whether “one step” or “two testing optimal, thresholds should be used. However, in context current coronavirus disease 2019 (COVID-19) pandemic, widespread anecdotal evidence suggests that both clinicians pregnant are increasingly unwilling recommend...

10.2337/dci20-0026 article EN Diabetes Care 2020-05-14

OBJECTIVE: To investigate relationships between dietary macronutrient intakes and glucose tolerance in pregnancy RESEARCH DESIGN AND METHODS: Nulliparous pregnant Chinese women diagnosed with gestational diabetes mellitus (GDM) (n = 56) were compared to age-, height-, parity-matched groups normal 77) intolerance (IGT) 38) based on the results of an oral test (National Diabetes Data Group criteria), performed 24 28 weeks pregnancy. A 24-h recall assessment was also obtained at time screening....

10.2337/diacare.23.4.460 article EN Diabetes Care 2000-04-01

To define the recurrence rate of gestational diabetes mellitus (GDM) in a subsequent pregnancy and to determine what factors could be predictive.The subjects index were 480 personally cared for women with GDM. One hundred had been tested GDM.The GDM was 35% (95% CI, 25.5-44.5). An increase weight between two pregnancies higher maternal age parity risk associates recurrence. A not associated glucose level, insulin use, or fetal birth pregnancy.GDM occurs only one-third pregnancies. Those who...

10.2337/diacare.19.12.1348 article EN Diabetes Care 1996-12-01

To examine anxiety levels of women diagnosed with gestational diabetes mellitus (GDM) and to compare these glucose-tolerant (GT) at similar stages pregnancy.Prospective longitudinal study conducted on 50 GDM GT women. All completed the Mental Health Inventory (MHI-5) forms Speilberger State-Trait Anxiety (STAI) beginning third trimester, antepartum, 6 weeks postpartum. Specific questions were also assessed using a Likert scale.Women GDM, compared women, had higher level (state rather than...

10.2337/diacare.26.2.385 article EN Diabetes Care 2003-02-01

Background/Aim. Dietary glycemic index (GI) has received considerable research interest over the past 25 years although its application to pregnancy outcomes is more recent. This paper critically evaluates current evidence regarding effect of dietary GI on maternal and fetal nutrition. Methods. A systematic literature search using MEDLINE, EMBASE, CINAHL, Cochrane Library, SCOPUS, ISI Web Science, from 1980 through September 2010, was conducted. Results. Eight studies were included in...

10.1155/2010/282464 article EN cc-by Journal of Nutrition and Metabolism 2010-01-01

It is clear that there remains a global crisis in the development and consequences of chronic diseases such as obesity type 2 diabetes.These conditions lead to complications increase morbidity mortality, heart disease, stroke, amputations, kidney disease.We have learned great deal about pathogenesis these disorders also both treatment preventive interventions.Clearly, considerable progress be made specifically addressing and, more importantly, preventing resourcepoor areas.Over recent past,...

10.2337/dci15-0030 article EN Diabetes Care 2015-12-14

To determine the effect of different seasons on prevalence gestational diabetes mellitus (GDM) by using World Health Organization criteria.The results all pregnancy glucose tolerance tests (GTTs) were prospectively collected over a 3-year period in temperate climate, and grouped season.The 7,369 GTTs available for consideration. In winter, median 1-h 2-h after GTT significantly (P < 0.0001) lower than overall results. The GDM at diagnostic level was 29% higher summer 27% winter = 0.02). 28%...

10.2337/dc16-0451 article EN Diabetes Care 2016-05-10

OBJECTIVE To present the results of a comprehensive dietary review group women with recurrence gestational diabetes mellitus (GDM), compared no GDM during subsequent pregnancy. RESEARCH DESIGN AND METHODS The intake 14 was 21 GDM. Women in one pregnancy have rate only 30–50%. While reasons for this not been determined, factors considered probable. RESULTS consumed 38.4 (by diet history) and 41.4% food record) their total energy as fats, 34.1 (P &amp;lt;0.01) 33.1% &amp;lt;0.001),...

10.2337/diacare.20.11.1647 article EN Diabetes Care 1997-11-01

The American Diabetes Association has recommended that pregnant women with low-risk factors need not be tested for gestational diabetes mellitus (GDM). aim of this study was to determine the prevalence GDM in and see if pregnancy outcomes from a group were different other GDM. RESEARCH DESION AND METHODS: Over an 18-month period, all offered test using 75-g glucose tolerance at beginning 3rd trimester. diagnosed 2-h level > or =8.0 mmol/l. determined defined (Caucasian ethnic origin, age <25...

10.2337/diacare.21.11.1803 article EN Diabetes Care 1998-11-01

OBJECTIVE—To investigate the efficacy and safety of acarbose as add-on therapy in overweight type 2 patients with diabetes inadequately controlled by metformin. RESEARCH DESIGN AND METHODS—This study adopted a multicenter, randomized, double-blind, placebo-controlled, parallel group design. After 4-week placebo run-in period, subjects were randomized to either (titrated up 100 mg b.i.d.) or placebo. The primary variable was change HbA1c from baseline end 24-week treatment period. Change...

10.2337/diacare.26.2.269 article EN Diabetes Care 2003-02-01

OBJECTIVE To examine selected pregnancy outcomes in women without gestational diabetes mellitus to see whether there was a continuum of risk related the maternal glucose level. RESEARCH DESIGN AND METHODS Consecutive attending two prenatal clinics and three obstetricians private practice were tested for GDM at beginning third trimester using 75-g load fasting state. The rate induction, number assisted deliveries, presence pregnancy-induced hypertension, fetal birth weights, morbidity...

10.2337/diacare.18.12.1527 article EN Diabetes Care 1995-12-01

Gestational diabetes mellitus (GDM) is one of the most common medical disorders found in pregnancy. Rates can range from 2 to >10%, and sometimes much higher, depending on population being tested diagnostic criteria used (1). The prevalence GDM ultimately reflects background rate type diabetes. There has also been an increase over last generation, possibly related community lifestyle factors as well better case ascertainment (2,3). ### Significance GDM GDM associated with a trilogy risks....

10.2337/dc09-0188 article EN cc-by-nc-nd Diabetes Care 2009-06-29
Coming Soon ...